-
Mashup Score: 6Pfizer Names New R&D Chief - 1 month(s) ago
Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1.
Source: www.wsj.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Mehmet Oz Named to Lead Centers for Medicare and Medicaid Services - 1 month(s) ago
Donald Trump said the TV personality would work closely with RFK Jr., his nominee for health secretary.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
Donald Trump named TV personality Mehmet Oz to lead the Centers for Medicare and Medicaid Services https://t.co/7t3fnE5zDk via @WSJ
-
-
Mashup Score: 0Lilly Sues U.S. to Change Hospital Drug Discount Payments - 1 month(s) ago
The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain hospitals.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
Eli Lilly sued a federal health agency that has blocked the company’s plan to tighten the way it provides lucrative drug discounts to hospitals, the second drugmaker to do so this week https://t.co/RlrjDQgaUz via @WSJ
-
-
Mashup Score: 3Trump to Pick RFK Jr. as Health Secretary - 1 month(s) ago
During the campaign, Kennedy abandoned his independent presidential bid and endorsed Trump
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
President-elect Donald Trump is planning to nominate environmental lawyer and vaccine skeptic Robert F. Kennedy, Jr. to serve as Health and Human Services secretary https://t.co/qI9BLKgp9H via @WSJ
-
-
Mashup Score: 0The Siblings Behind RFK Jr.’s ‘Make America Healthy Again’ Campaign - 1 month(s) ago
The wellness-minded pair, poised to shape Donald Trump’s health agenda, represent a sharp break from his first term.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
Meet the RFK Jr.-approved, wellness-minded sibling duo poised to shape Donald Trump’s health agenda https://t.co/HawgG0YSsu via @WSJ
-
-
Mashup Score: 1J&J Sues U.S. Over Hospital Drug-Discounting Program - 1 month(s) ago
The company filed a lawsuit asking for a federal court’s permission to change when it gives lucrative drug discounts to hospitals.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
J&J has sued a U.S. health agency blocking the company’s plans to tighten the way it provides lucrative drug discounts to hospitals https://t.co/PKacPaSn1Z via @WSJ
-
-
Mashup Score: 2
Antitrust enforcers argue that the healthcare giant’s latest deal would illegally harm competition.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
The Justice Department sued to block UnitedHealth Group’s $3.3 billion acquisition of Amedisys, alleging the deal would give the health-industry giant too much power over the market for home health and hospice services https://t.co/judVSBTlpk via @WSJ
-
-
Mashup Score: 3
Medicare Advantage patients in the last year of life were far more likely to switch to traditional Medicare, shifting costs from insurers.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
The sickest patients are dropping private Medicare Advantage plans for traditional Medicare, shifting billions in costs from insurers to taxpayers. “I started freaking out.” https://t.co/SbvNUcFBP5 via @WSJ
-
-
Mashup Score: 2
U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
U.S. drugmakers have come to rely on Chinese partners in their supply chains. Now, some of them are looking for alternatives as geopolitical tensions rise https://t.co/VzQSHjhScp via @WSJ
-
-
Mashup Score: 3AstraZeneca Probe in China Adds to Concerns for Foreign Businesses - 2 month(s) ago
An investigation involving the drugmaker’s China president is the latest industry crackdown to trigger uncertainty about Beijing’s intentions.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet-
An investigation involving a top executive at drugmaker AstraZeneca is the latest to rattle foreign companies in China https://t.co/Enh0lOdI3K via @WSJ
-
Pfizer has selected Chris Boshoff, an accomplished scientist who has been leading the company’s cancer-drugs business, to oversee all research and development https://t.co/yRnpdUm63J via @WSJ